Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
Powell MA, Filiaci VL, Hensley ML, Huang HQ, Moore KN, Tewari KS, Copeland LJ, Secord AA, Mutch DG, Santin A, Warshal DP, Spirtos NM, DiSilvestro PA, Ioffe OB, Miller DS.
J Clin Oncol. 2022 Mar 20;40(9):968-977. doi: 10.1200/JCO.21.02050. Epub 2022 Jan 10.
PMID:35007153
Carcinosarcoma of the ovary: a review of the literature.
del Carmen MG, Birrer M, Schorge JO.
Gynecol Oncol. 2012 Apr;125(1):271-7. doi: 10.1016/j.ygyno.2011.12.418. Epub 2011 Dec 8.
PMID:22155675
"Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".
Rauh-Hain JA, Birrer M, Del Carmen MG.
Gynecol Oncol. 2016 Aug;142(2):248-54. doi: 10.1016/j.ygyno.2016.06.003. Epub 2016 Jun 16.